Pretreatment maximum standardized uptake value on 18F‐fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non‐small cell lung cancer after stereotactic body radiotherapy
Pretreatment maximum standardized uptake value on 18F‐fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non‐small cell lung cancer after stereotactic body radiotherapy
复制标题
DOI：
10.1111/ajco.12128
复制
发表时间：
2016-03
期刊：
影响因子：
--
通讯作者：
Hidekazu Tanaka;S. Hayashi;H. Hoshi
中科院分区：
文献类型：
--
作者：
Hidekazu Tanaka;S. Hayashi;H. Hoshi
立体定向体部放疗（SBRT）通常被认为是有手术禁忌症或拒绝手术的I期非小细胞肺癌（NSCLC）患者的重要治疗选择。许多研究报道，原发肿瘤18F-氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）的最大标准化摄取值（SUVmax）对切除的NSCLC具有预后价值。本研究的目的是确定SUVmax是否是SBRT后I期NSCLC患者无病生存期（DFS）的预测因子。
Stereotactic body radiotherapy (SBRT) is commonly considered an important treatment option for patients with stage I non‐small cell lung cancer (NSCLC) who have contraindications for surgery or refuse surgery. Many studies have reported that the maximum standardized uptake value (SUVmax) on 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) of the primary tumor has prognostic value for resected NSCLC. The purpose of this study was to determine whether SUVmax is a predictor of disease‐free survival (DFS) in patients with stage I NSCLC after SBRT.